- arvato Systems and the GUS Group enter into a strategic partnership in the pharmaceutical field
- arvato Systems and the GUS Group provide pharmaceutical companies with a comprehensive IT solution to meet current global serialization requirements
Drug safety and counterfeit medications are currently important topics in the pharmaceuticals industry. An end-to-end verification process is therefore set to solve the problem of an increasing number of counterfeit medications in the EU by 2018. The pharmaceuticals industry will then be under obligation to generate a unique serial number and print it on the boxes of medicinal products. The serial number must also be stored in accordance with the highest security standards, a process that is only possible using IT.
OCS and arvato Systems have developed the arvato CSDB solution that allows pharmaceutical companies to meet the upcoming requirements of the EU Falsified Medicines Directive along the entire production and supply chain, and consistently integrate them into their production processes.
The Cologne-based GUS Group, one of the leading providers of ERP applications, offers an ERP solution as a platform for all processes in the industrial fields of pharmaceuticals, food, chemicals, biotechnology, medicine, cosmetics, and logistics. Its solution enables the GUS Group to serve as a successful partner to the sensitive pharmaceutical industry, where product quality and process reliability take priority. “arvato CSDB and our strategic partnership with the company allow us to expand our range of products and services in the pharmaceutical sector,” explains Jörg Paul Zimmer, Director of Pharmaceuticals and Chemicals at GUS Deutschland GmbH. Peter Koop, Director of Pharmaceutical Solutions at arvato Systems, adds, “We are delighted to now be able to offer a sustainable industry solution in arvato CSDB with the GUS Group. Alongside the vital contribution towards combating falsified medicine, we also believe there is massive potential for serialization in supply chain optimization, which we are looking to tap with our customers and the GUS Group.”
Successful presentation of the integrated system at the GUS customer event, with next joint event planned for October in Berlin, Germany
At this year’s GUS customer event, arvato Systems and the GUS Group used live demonstrations to present the IT solution to a large group of customers. The next arvato Systems event, entitled ‘Serialization in the Pharmaceuticals Industry: Best Practices for the Future,’ is being held in conjunction with the GUS Group in Berlin on 21 October 2014. You can find more information on the conference, the topic, and the solutions available in this area here.
About the GUS Group
The GUS Group is a leading provider of integrated enterprise solutions for sectors with a strong focus on quality, including the pharmaceutical, biotechnology, chemicals, food, cosmetics, medical technology, and logistics service industries. It has extensive expertise in best practices, methods, and functions gained in more than 300 business process optimization projects. Along with the GUS-OS Suite as a central solution package for nearly every department within an enterprise, industry-focused consultants, project managers, and application developers ensure that this edge in industry, IT, and business knowledge and expertise is deployed in a way that fosters the customer’s business success achieved through the proper balance of quality, efficiency, precision, and streamlining. The GUS Group is the process specialist for small and medium-sized companies in Central Europe, with approximately 150 employees at three locations in Germany as well as affiliates in Switzerland and Denmark.